Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Lee Jackson | Oct 12, 2016 at 9:55 AM EDT

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

Jefferies highlights top growth stocks to buy each week, and this week is no exception. These four all make good…

Chris Lange | Oct 12, 2016 at 7:45 AM EDT

Accelerated Pharma Announces Expected Price Range for IPO

Accelerated Pharma intends to price less than 2 million shares in the range of $8 to $10 for an initial…

Chris Lange | Oct 12, 2016 at 7:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Chris Lange | Oct 12, 2016 at 7:10 AM EDT

Short Sellers Have Mixed Views on Major Biotechs

If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a…

Chris Lange | Oct 11, 2016 at 3:30 PM EDT

Biostar Pharma Skyrockets on New Chinese Product Launch

Biostar Pharmaceuticals Inc. (NASDAQ: BSPM) is watching its shares nearly double on Tuesday after the company announced that it is releasing…

Chris Lange | Oct 11, 2016 at 12:05 PM EDT

Nymox Wins Big on Late-Stage Trial

Nymox Pharmaceutical shares jumped following the announcement of positive results from its late-stage prostate cancer trial.

Chris Lange | Oct 11, 2016 at 10:40 AM EDT

KemPharm Rises on Key FDA Approval

KemPharm shares saw a solid gain on Tuesday following a key FDA approval on it treatment for attention deficit hyperactivity…

Chris Lange | Oct 11, 2016 at 9:15 AM EDT

Merrimack Pharma Rises on Positive Late-Stage Results

Merrimack Pharmaceuticals shares saw a handy gain early Tuesday after the company announced positive results for its late stage metastatic…

Chris Lange | Oct 11, 2016 at 8:35 AM EDT

Illumina Stumbles Over Q3 Sales Update

When Illumina issued an update on its sales for the third quarter, the numbers came in below what analysts were…

Chris Lange | Oct 10, 2016 at 4:08 PM EDT

Mazor Robotics Rises on Pre-Launch Orders

Mazor Robotics Ltd. (NASDAQ: MZOR) is watching its shares rise handily on Monday after the company announced that it has…

Chris Lange | Oct 10, 2016 at 3:04 PM EDT

IntelliPharmaCeutics Soars on Tentative FDA Approval

IntelliPharmaCeutics International Inc. (NASDAQ: IPCI) is watching its shares jump on Monday after the company announced that it received a…

Paul Ausick | Oct 10, 2016 at 1:59 PM EDT

Mylan Strikes Deal with US DoJ, Stock Recovers

Shares of EpiPen maker Mylan NV (NASDAQ: MYL) rose nearly 12.5% early Monday following the company’s announcement after markets closed…

Jon C. Ogg | Oct 10, 2016 at 12:05 PM EDT

Analysts Chase Tesaro Targets and Ratings Higher

Several analysts have weighed in with higher price targets on top of their ratings for Tesaro. Its shares hit a…

Chris Lange | Oct 10, 2016 at 11:25 AM EDT

Monday’s 3 Major Biopharma Movers

On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.

Chris Lange | Oct 10, 2016 at 8:40 AM EDT

Exelixis Continues Massive Run With Positive Cabosun Results

Shares of Exelixis saw a handy gain early Monday morning after the company reported positive results from its mid-stage trial…

1 … 190 191 192 193 194 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

Accelerated Pharma Announces Expected Price Range for IPO

Major Pharma Short Sellers Grow More Selective

Short Sellers Have Mixed Views on Major Biotechs

Biostar Pharma Skyrockets on New Chinese Product Launch

Nymox Wins Big on Late-Stage Trial

KemPharm Rises on Key FDA Approval

Merrimack Pharma Rises on Positive Late-Stage Results

Illumina Stumbles Over Q3 Sales Update

Mazor Robotics Rises on Pre-Launch Orders

IntelliPharmaCeutics Soars on Tentative FDA Approval

Mylan Strikes Deal with US DoJ, Stock Recovers

Analysts Chase Tesaro Targets and Ratings Higher

Monday’s 3 Major Biopharma Movers

Exelixis Continues Massive Run With Positive Cabosun Results

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

Accelerated Pharma Announces Expected Price Range for IPO

Major Pharma Short Sellers Grow More Selective

Short Sellers Have Mixed Views on Major Biotechs

Biostar Pharma Skyrockets on New Chinese Product Launch

Nymox Wins Big on Late-Stage Trial

KemPharm Rises on Key FDA Approval

Merrimack Pharma Rises on Positive Late-Stage Results

Illumina Stumbles Over Q3 Sales Update

Mazor Robotics Rises on Pre-Launch Orders

IntelliPharmaCeutics Soars on Tentative FDA Approval

Mylan Strikes Deal with US DoJ, Stock Recovers

Analysts Chase Tesaro Targets and Ratings Higher

Monday’s 3 Major Biopharma Movers

Exelixis Continues Massive Run With Positive Cabosun Results

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check